BRAFL597 mutations in melanoma are associated with sensitivity to MEK inhibitors

BRAFL597 mutations in melanoma are associated with sensitivity to MEK inhibitors. Dahlman, K. B., Xia, J., Hutchinson, K., Ng, C., Hucks, D., Jia, P., Atefi, M., Su, Z., Branch, S., Lyle, P. L., Hicks, D. J., Bozon, V., Glaspy, J. A., Rosen, N., Solit, D. B., Netterville, J. L., Vnencak-Jones, C. L., Sosman, J. A., Ribas, A., Zhao, Z., & Pao, W. Cancer Discovery, 2(9):791–797, 2012.
doi bibtex

@article{Dahlman2012,
    author = {Dahlman, Kimberly Brown and Xia, Junfeng and Hutchinson, Katherine and Ng, Charles and Hucks, Donald and Jia, Peilin and Atefi, Mohammad and Su, Zengliu and Branch, Suzanne and Lyle, Pamela L. and Hicks, Donna J. and Bozon, Viviana and Glaspy, John A. and Rosen, Neal and Solit, David B. and Netterville, James L. and Vnencak-Jones, Cindy L. and Sosman, Jeffrey A. and Ribas, Antoni and Zhao, Zhongming and Pao, William},
    doi = {10.1158/2159-8290.CD-12-0097},
    isbn = {6153439454},
    issn = {21598274},
    journal = {Cancer Discovery},
    number = {9},
    pages = {791--797},
    pmid = {22798288},
    title = {{BRAFL597 mutations in melanoma are associated with sensitivity to MEK inhibitors}},
    volume = {2},
    year = {2012}
}

Downloads: 0